These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 513194)

  • 1. Species specificity of interferon action: maintenance and establishment of the antiviral state in the presence of a heterospecific nucleus.
    Veomett MJ; Veomett GE
    J Virol; 1979 Sep; 31(3):785-94. PubMed ID: 513194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-mediated development of influenza virus resistance in hybrids between Mx gene-bearing and control mouse embryo fibroblasts.
    Ruff M
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1291-300. PubMed ID: 6189964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species specificity of interferon action: a functioning homospecific nucleus is required for induction of antiviral activity in heterokaryons.
    Sakaguchi AY; Stevenson D; Gordon I
    Virology; 1982 Jan; 116(2):441-53. PubMed ID: 6175077
    [No Abstract]   [Full Text] [Related]  

  • 4. Establishment and maintenance of the interferon-induced antiviral state: studies in enucleated cells.
    Radke KL; Colby C; Kates JR; Krider HM; Prescott DM
    J Virol; 1974 Mar; 13(3):623-30. PubMed ID: 4362865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I topoisomerase activity after infection of enucleated, synchronized mouse L cells by vaccinia virus.
    Poddar SK; Bauer WR
    J Virol; 1986 Feb; 57(2):433-7. PubMed ID: 3003375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interferon-induced refractory state of L cells: role of the nucleus and cytoplasm.
    Lahm BD; Veomett G
    J Gen Virol; 1980 Aug; 49(2):447-52. PubMed ID: 6160198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinia virus replication. I. Requirement for the host-cell nucleus.
    Hruby DE; Guarino LA; Kates JR
    J Virol; 1979 Feb; 29(2):705-15. PubMed ID: 107327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures.
    Youngner JS; Thacore HR; Kelly ME
    J Virol; 1972 Aug; 10(2):171-8. PubMed ID: 4342236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of serum on the antiviral and anticellular activities of mouse interferon.
    Kading VH; Blalock JE; Gifford GE
    Arch Virol; 1978; 56(3):237-42. PubMed ID: 205196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse fibroblast (type I) and immune (type II) interferons: pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells.
    Ankel H; Krishnamurti C; Besançon F; Stefanos S; Falcoff E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2528-32. PubMed ID: 6156452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.
    Rice AP; Roberts WK; Kerr IM
    J Virol; 1984 Apr; 50(1):220-8. PubMed ID: 6422053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of human chromosome 21 alone is sufficient for hybrid cell sensitivity to human interferon.
    Slate DL; Shulman L; Lawrence JB; Revel M; Ruddle FH
    J Virol; 1978 Jan; 25(1):319-25. PubMed ID: 202744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal by hypotonic medium of the antiviral state induced by lymphoblastoid interferon in human HeLa cells.
    Muñoz A; Carrasco L
    Intervirology; 1981; 16(2):106-13. PubMed ID: 6173348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-mediated antiviral state in human MRC5 cells in the absence of detectable levels of 2-5A synthetase and protein kinase.
    Meurs E; Hovanessian AG; Montagnier L
    J Interferon Res; 1981 Feb; 1(2):219-32. PubMed ID: 6180053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of rRNA in interferon-treated vaccinia virus-infected cells.
    Goswami BB; Sharma OK
    J Biol Chem; 1984 Feb; 259(3):1371-4. PubMed ID: 6198324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. I. Rescue in cell cultures from different species.
    Thacore HR; Youngner JS
    Virology; 1973 Dec; 56(2):505-11. PubMed ID: 4357053
    [No Abstract]   [Full Text] [Related]  

  • 17. Indiscriminate degradation of RNAs in interferon-treated, vaccinia virus-infected mouse L cells.
    Benavente J; Paez E; Esteban M
    J Virol; 1984 Sep; 51(3):866-71. PubMed ID: 6206238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts.
    Friedman RM; Metz DH; Esteban RM; Tovell DR; Ball LA; Kerr IM
    J Virol; 1972 Dec; 10(6):1184-98. PubMed ID: 4345494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative antiviral resistance induced in homologous and heterologous cells by cross-reacting interferons.
    Stewart WE; Lockart RZ
    J Virol; 1970 Dec; 6(6):795-9. PubMed ID: 4322082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of input multiplicity of infection on the antiviral activity of interferon.
    Stitz L; Schellekens H
    J Gen Virol; 1980 Jan; 46(1):205-10. PubMed ID: 6243342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.